155 related articles for article (PubMed ID: 12803214)
1. Celecoxib versus diclofenac and omeprazole to prevent recurrent ulcer bleeding.
McKeogh DF
N Engl J Med; 2003 Jun; 348(24):2464-6; author reply 2464-6. PubMed ID: 12803214
[No Abstract] [Full Text] [Related]
2. [Antiplatelet drugs and gastrointestinal bleeding: numquam periclum sine periclo vincitur].
Rossini R; Lucà MG; Scuri P; Invernizzi P; Strazzabosco M; Gavazzi A
Ital Heart J Suppl; 2005 Oct; 6(10):621-6. PubMed ID: 16273749
[No Abstract] [Full Text] [Related]
3. Aspirin and gastrointestinal toxicity.
Törüner M
Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():27-30. PubMed ID: 18160364
[TBL] [Abstract][Full Text] [Related]
4. [Gastrointestinal bleeding during low dose acetylsalicylic acid. Is Godamed-100 TAH an alternative to conventional ASS preparations?].
Maywald U; Schindler C
Dtsch Med Wochenschr; 2005 Apr; 130(16):1026-7. PubMed ID: 15830316
[No Abstract] [Full Text] [Related]
5. Bleeding risk with aspirin must be balanced against benefit.
Harv Heart Lett; 2012 Aug; 22(12):8. PubMed ID: 23025025
[No Abstract] [Full Text] [Related]
6. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
Limmer S; Ittel TH; Wietholtz H
Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
[TBL] [Abstract][Full Text] [Related]
7. Is low-dose aspirin safe for you? If you take daily aspirin, make sure you know why and understand the small but real bleeding risk.
Harv Mens Health Watch; 2012 Oct; 17(3):3. PubMed ID: 23175863
[No Abstract] [Full Text] [Related]
8. A health impact assessment of increased aspirin use in Wales.
Williams WR
Public Health; 2006 May; 120(5):480; author reply 481. PubMed ID: 16549078
[No Abstract] [Full Text] [Related]
9. Strategies to reduce the GI risks of antiplatelet therapy.
Scheiman JM
Rev Cardiovasc Med; 2005; 6 Suppl 4():S23-31. PubMed ID: 17710073
[TBL] [Abstract][Full Text] [Related]
10. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.
Bhatt DL; Scheiman J; Abraham NS; Antman EM; Chan FK; Furberg CD; Johnson DA; Mahaffey KW; Quigley EM; Harrington RA; Bates ER; Bridges CR; Eisenberg MJ; Ferrari VA; Hlatky MA; Kaul S; Lindner JR; Moliterno DJ; Mukherjee D; Schofield RS; Rosenson RS; Stein JH; Weitz HH; Wesley DJ;
J Am Coll Cardiol; 2008 Oct; 52(18):1502-17. PubMed ID: 19017521
[No Abstract] [Full Text] [Related]
11. Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: a meta-analysis of randomized trials.
Berger JS; Lala A; Krantz MJ; Baker GS; Hiatt WR
Am Heart J; 2011 Jul; 162(1):115-24.e2. PubMed ID: 21742097
[TBL] [Abstract][Full Text] [Related]
12. Aspirin: real benefits, but real risks, too.
Harv Heart Lett; 1999 May; 9(9):1-3. PubMed ID: 10200029
[No Abstract] [Full Text] [Related]
13. Ethical considerations in relation to aspirin prophylaxis.
Morgan G
Qual Prim Care; 2008; 16(6):433-40. PubMed ID: 19094419
[TBL] [Abstract][Full Text] [Related]
14. Should patients stop taking aspirin for primary prevention?
Depta JP; Bhatt DL
Cleve Clin J Med; 2015 Feb; 82(2):91-6. PubMed ID: 25897597
[No Abstract] [Full Text] [Related]
15. Aspirin withdrawal in acute peptic ulcer bleeding: are we harming patients?
Barkun AN; Bardou M
Ann Intern Med; 2010 Jan; 152(1):52-3, W-12. PubMed ID: 19949134
[No Abstract] [Full Text] [Related]
16. Aspirin for the prevention of cardiovascular disease.
Lin KW
Am Fam Physician; 2011 Jun; 83(12):1469-70. PubMed ID: 21671548
[No Abstract] [Full Text] [Related]
17. A case-control study of the association between polymorphisms of the endothelial nitric oxide synthase and glycoprotein IIIa genes and upper gastrointestinal bleeding in users of low-dose aspirin.
Piazuelo E; Fuentes J; García-González MA; Jiménez P; Lanas A
Clin Ther; 2008 Jan; 30(1):121-30. PubMed ID: 18343248
[TBL] [Abstract][Full Text] [Related]
18. Benefits versus risks of aspirin in cardioprotection: dangers of heart attack after discontinuation.
Wynn RL
Gen Dent; 2012; 60(4):255-8. PubMed ID: 22782034
[No Abstract] [Full Text] [Related]
19. Upper GI risks of NSAIDs and antiplatelet agents: key issues for the cardiologist.
Johnson DA
Rev Cardiovasc Med; 2005; 6 Suppl 4():S15-22. PubMed ID: 17710072
[TBL] [Abstract][Full Text] [Related]
20. [Gastroenterology in family practice. Updates for your "stomach patient"].
Stiefelhagen P
MMW Fortschr Med; 2006 Jun; 148(22):4-6. PubMed ID: 16821566
[No Abstract] [Full Text] [Related]
[Next] [New Search]
